CardioScale Wins The Combating Terrorism Technology StartUp Challange (CTTSC3) Presented by The US Department of Defence (CTTSO), Israel...

CardioScale Ltd. announces that the application for its proprietary CVRI Index has been approved by the Australian Authority IP...

CardioScale Ltd. Announces that its proprietary CVRI Index has been approved by both the Chinese and Japanese Patent Authorities, giving...

CardioScale announced today that its Patent in Mainland China had successfully passed examination and was fully granted. The company...

The company specializing in early detection of hemodynamic deterioration based on its innovative technology announced today that the U.S....

Innovation in Emergency Medicine, Preparedness, Management & Rehabilitation. Paris – France | 24 – 25 April, 2017 Sharing the best...

Taiwan is a country with advanced medical technology, high-efficient infrastructure, and potential aging markets nearby. In 2016...

We are delighted to inform that CardioScale's abstract has been selected by the Congress Scientific Committee to present its studies: ...